Harbour Investments’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Harbour Investments's BIIB Position: Q2 2026 in Review
Harbour Investments increased its Biogen (BIIB) stake by 1.6% in Q2 2026, buying an estimated $956 and bringing the position to 325 shares worth $70.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2215.
Harbour Investments first reported a position in BIIB in Q1 2021 and has held it in 21 quarters since. The position peaked at $267K in Q2 2021. 1,046 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Harbour Investments held 325 shares of Biogen worth $70.2K as of Q2 2026.
- Harbour Investments bought 5 Biogen shares in Q2 2026, an estimated $956.
- Biogen made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #2215 holding.
- Harbour Investments first reported a position in Biogen in Q1 2021 and has held it in 21 quarters since.
- Harbour Investments's Biogen position peaked at $267K in Q2 2021.
- 1,046 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.